Monopar Therapeutics Inc. (MNPR)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20263 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Monopar Therapeutics Inc.’s names, not what it holds today.
2 published
2 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 17, 2021 | 11,090,290 | Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy | Pharmaceuticals | Monopar Therapeutics Inc. |
| Jun 9, 2020 | 10,675,271 | Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy | Pharmaceuticals | Monopar Therapeutics Inc. |
| Oct 22, 2019 | 10,450,340 | 3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation | Organic fine chemistry | Monopar Therapeutics Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 26, 2023 | 2023/0338590 | MATERIALS AND METHODS FOR TREATING CORONAVIRUS | Pharmaceuticals | MONOPAR THERAPEUTICS INC. |
| Dec 29, 2022 | 2022/0409751 | Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceutical | Pharmaceuticals | Monopar Therapeutics Inc. |
| Dec 1, 2022 | 2022/0378956 | Trivalent Radioisotope Bio-Targeted Radiopharmaceutical, Methods Of Preparation And Use | Pharmaceuticals | Monopar Therapeutics Inc. |
| Apr 12, 2018 | 2018/0098967 | CLONIDINE AND/OR CLONIDINE DERIVATIVES FOR USE IN THE PREVENTION OF SKIN INJURY RESULTING FROM RADIOTHERAPY | Pharmaceuticals | MONOPAR THERAPEUTICS INC. · patent 11,090,290 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.